Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 866 entries
View as:

A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197

Phase: N/A Priority: Normal
NCT ID: NCT02429895 Org: User:
Start: 10/31/15 End: 05/31/16 Due: 05/31/17

A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03022045 Org: User:
Start: 01/26/17 End: 11/19/20 Due: 11/19/21

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Phase: N/A Priority: Normal
NCT ID: NCT02016690 Org: User:
Start: 12/31/13 End: 12/31/15 Due: 12/31/16

An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)

Phase: N/A Priority: Normal
NCT ID: NCT02451839 Org: User:
Start: 07/06/15 End: 12/05/17 Due: 12/05/18

A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02099058 Org: User:
Start: 01/15/14 End: 11/30/25 Due: 11/30/26

Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06937034 Org: User:
Start: 04/14/25 End: 05/31/25 Due: 05/31/26

Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine

Phase: N/A Priority: Normal
NCT ID: NCT05264129 Org: User:
Start: 03/07/22 End: 04/04/23 Due: 04/04/24

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04086264 Org: User:
Start: 11/06/19 End: 02/28/27 Due: 02/28/28

A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06946524 Org: User:
Start: 05/08/25 End: 12/31/25 Due: 12/31/26

Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)

Phase: N/A Priority: Normal
NCT ID: NCT02806362 Org: User:
Start: 09/30/16 End: 08/31/18 Due: 08/31/19

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01777165 Org: User:
Start: 02/28/13 End: 03/31/14 Due: 03/31/15

A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT05486195 Org: User:
Start: 03/14/19 End: 03/11/20 Due: 03/11/21

A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration

Phase: N/A Priority: Normal
NCT ID: NCT05995366 Org: User:
Start: 08/18/23 End: 10/13/23 Due: 10/13/24

Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01860846 Org: User:
Start: 05/31/13 End: 02/29/16 Due: 02/28/17

Expanded Access to Bimatoprost (Durysta)

Phase: N/A Priority: Normal
NCT ID: NCT05338606 Org: User:
Start: - End: - Due: -

Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05158894 Org: User:
Start: 01/10/23 End: 09/30/34 Due: 09/30/35

Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT05411198 Org: User:
Start: 07/22/22 End: 08/15/25 Due: 08/15/26

A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT06487559 Org: User:
Start: 09/11/24 End: 10/31/27 Due: 10/31/28

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT04721002 Org: User:
Start: 07/07/21 End: 09/30/23 Due: 09/30/24

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

Phase: N/A Priority: Normal
NCT ID: NCT05669794 Org: User:
Start: 02/21/23 End: 02/28/27 Due: 02/28/28

A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)

Phase: N/A Priority: Normal
NCT ID: NCT03987958 Org: User:
Start: 08/08/19 End: 07/31/27 Due: 07/31/28

A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06618118 Org: User:
Start: 10/23/24 End: 11/30/26 Due: 11/30/27

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT04161885 Org: User:
Start: 02/26/20 End: 11/30/26 Due: 11/30/27

A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT05414201 Org: User:
Start: 07/07/22 End: 06/10/24 Due: 06/10/25

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT07023302 Org: User:
Start: 06/20/25 End: 02/28/29 Due: 02/28/30